Clinical Trial: Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629167) titled 'Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway' on June 01.

Brief Summary: A phase 2 study testing the efficacy of isotretinoin versus doxycycline in treating participants who develop a acneiform rash caused by standard of care, tumor-directed therapies targeting the mitogenactivated protein kinase (MAPK) pathway.

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: Acneiform Drug Eruption Acneiform Eruptions

Intervention: DRUG: Isotretinoin

Given Orally

DRUG: Doxycycline

Given Orally

PROCEDURE: Blood specimen collection

Perform blood draw

OTHER: Photogr...